Teva Pharmaceutical Industries ADR
(TEVA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1995 | 12-1994 | 12-1993 | 12-1992 | 12-1991 | |
| Sales | 667,670 | 587,710 | 501,975 | 396,336 | 320,983 |
| Cost of Goods | 389,510 | 329,230 | 288,120 | 241,949 | 203,949 |
| Gross Profit | 278,150 | 258,470 | 213,855 | 154,387 | 267,189 |
| Operating Expenses | 168,240 | 151,970 | 125,994 | 100,607 | 102,717 |
| Operating Income | 110,430 | 106,740 | 87,981 | 54,729 | 15,266 |
| Interest Expense | 8,470 | 8,740 | 0 | 0 | 0 |
| Other Income | 4,740 | -20 | -2,780 | -3,403 | 21,107 |
| Pre-tax Income | 106,700 | 97,980 | 85,201 | 51,326 | 36,373 |
| Income Tax | 27,900 | 27,020 | 27,526 | 19,466 | 13,013 |
| Net Income Continuous | 83,618 | 71,646 | 57,475 | 62,496 | 23,300 |
| Net Income | $79,790 | $71,640 | $57,475 | $31,734 | $23,282 |
| EPS Basic Total Ops | 0.18 | 0.17 | 0.13 | 0.01 | 0.04 |
| EPS Basic Continuous Ops | 0.19 | 0.16 | 0.01 | 0.01 | 0.00 |
| EPS Diluted Total Ops | 0.18 | 0.17 | 0.13 | 0.01 | 0.00 |
| EPS Diluted Continuous Ops | 0.19 | 0.16 | 0.01 | 0.01 | 0.00 |
| EBITDA(a) | $110,430 | $106,740 | $107,582 | $54,729 | $28,784 |